This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Clinical Trial

. 1971 Dec 13;218(11):1704-5.

The UGDP study

PMID: 4940315

Clinical Trial

The UGDP study

D S Salsburg. JAMA. 1971.

. 1971 Dec 13;218(11):1704-5.

Author

PMID: 4940315

No abstract available

PubMed Disclaimer

Similar articles

Effects of hypoglycemic agents on vascular complications in patients with adult-onset diabetes. IV. A preliminary report on phenoformin results.
Knatterud GL, Meinert CL, Klimt CR, Osborne RK, Martin DB. Knatterud GL, et al. JAMA. 1971 Aug 9;217(6):777-84. JAMA. 1971. PMID: 4935344 Clinical Trial. No abstract available.
A study of the effects of hypoglycemic agents on vascular complications in patients with adult-onset diabetes. II. Mortality results.
Meinert CL, Knatterud GL, Prout TE, Klimt CR. Meinert CL, et al. Diabetes. 1970;19:Suppl:789-830. Diabetes. 1970. PMID: 4926376 Clinical Trial. No abstract available.
The UGDP--tolbutamide and mortality.
Knowles HC Jr. Knowles HC Jr. Horm Metab Res. 1974;Suppl 4:186-8. Horm Metab Res. 1974. PMID: 4609432 Clinical Trial. No abstract available.
[25 years of diabetic treatment by oral hypoglycemic agents: successes and failures].
Tattersall RB. Tattersall RB. Journ Annu Diabetol Hotel Dieu. 1984:183-91. Journ Annu Diabetol Hotel Dieu. 1984. PMID: 6443219 Review. French. No abstract available.
Antidiabetic agents and vascular events.
Keen H. Keen H. J Clin Pathol Suppl (R Coll Pathol). 1975;9:99-105. J Clin Pathol Suppl (R Coll Pathol). 1975. PMID: 783218 Free PMC article. Review. No abstract available.

See all similar articles

Cited by

Comment on: Evans JMM, Ogston SA, Emslie-Smith A, Morris AD (2006) Risk of mortality and adverse cardiovascular outcomes in type 2 diabetes: a comparison of patients treated with sulfonylureas and metformin. Diabetologia 49:930-936.
Raccah D. Raccah D. Diabetologia. 2007 May;50(5):1109-10; author reply 1111. doi: 10.1007/s00125-007-0630-3. Epub 2007 Mar 10. Diabetologia. 2007. PMID: 17351766 No abstract available.
Cardiovascular outcome trials for anti-diabetes medication: A holy grail of drug development?
John M, Gopalakrishnan Unnikrishnan A, Kalra S, Nair T. John M, et al. Indian Heart J. 2016 Jul-Aug;68(4):564-71. doi: 10.1016/j.ihj.2016.02.017. Epub 2016 Apr 11. Indian Heart J. 2016. PMID: 27543483 Free PMC article. Review.
Jerome Cornfield's Bayesian approach to assessing interim results in clinical trials.
Schlesselman JJ. Schlesselman JJ. J R Soc Med. 2016 Jan;109(1):27-35. doi: 10.1177/0141076815621243. J R Soc Med. 2016. PMID: 26801994 Free PMC article. No abstract available.
Sulfonylurea in combination with insulin is associated with increased mortality compared with a combination of insulin and metformin in a retrospective Danish nationwide study.
Mogensen UM, Andersson C, Fosbøl EL, Schramm TK, Vaag A, Scheller NM, Torp-Pedersen C, Gislason G, Køber L. Mogensen UM, et al. Diabetologia. 2015 Jan;58(1):50-8. doi: 10.1007/s00125-014-3372-z. Epub 2014 Sep 10. Diabetologia. 2015. PMID: 25205223
One Small Step for Empagliflozin, One Giant Leap for Diabetology.
Kalra S. Kalra S. Diabetes Ther. 2015 Dec;6(4):405-409. doi: 10.1007/s13300-015-0144-9. Epub 2015 Nov 4. Diabetes Ther. 2015. PMID: 26537704 Free PMC article.

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Silverchair Information Systems